|
|
1. |
Cossart YE, Field AM, Cant B, Widdows D. Parvovirus-like particles in human sera. Lancet 1975;1:72–73.
|
|
2. |
Santagostino E, Mannucci PM, Gringeri A, Azzi A, Morfini M. Eliminating parvovirus B19 from blood products. Lancet 1994;343:798.
|
|
3. |
Anderson LJ. Human parvoviruses. J Infect Dis 1990;161:603–608.
|
|
4. |
Lee YJ, So BJ, Chae KM, Jeong BH. A case of pure red cell aplasia due to parvovirus B19 in renal transplantation. Korean J Hematol 1999;34:646–650.
|
|
5. |
Setúbal S, de Oliveira SA, Pires AR, da Fonseca EC, Camacho LA, Seródio AC, et al. Erythrovirus B19 infection in acquired immunodeficiency syndrome: screening by histopathology, immunohistochemistry, and in situ hybridization. Mem Inst Oswaldo Cruz 2006;101:407–414.
|
|
6. |
Kerr JR, Curran MD, Moore JE, Coyle PV, Ferguson WP. Persistent parvovirus B19 infection. Lancet 1995;345:1118.
|
|
7. |
Musiani M, Zerbini M, Gentilomi G, Plazzi M, Gallinella G, Venturoli S. Parvovirus B19 clearance from peripheral blood after acute infection. J Infect Dis 1995;172:1360–1363.
|
|
8. |
Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med 1989;321:519–523.
|
|
9. |
Ramage JK, Hale A, Gane E, Cohen B, Boyle M, Mufti G, et al. Parvovirus B19-induced red cell aplasia treated with plasmapheresis and immunoglobulin. Lancet 1994;343:667–668.
|
|
10. |
Chang FY, Singh N, Gayowski T, Marino IR. Parvovirus B19 infection in a liver transplant recipient: case report and review in organ transplant recipients. Clin Transplant 1996;10:243–247.
|
|
11. |
Misra S, Moore TB, Ament ME, Busuttil RW, McDiarmid SV. Red cell aplasia in children on tacrolimus after liver transplantation. Transplantation 1998;65:575–577.
|
|
12. |
Liang TB, Li DL, Yu J, Bai XL, Liang L, Xu SG, et al. Pure red cell aplasia due to parvovirus B19 infection after liver transplantation: a case report and review of the literature. World J Gastroenterol 2007;13:2007–2010.
|
|
13. |
Nour B, Green M, Michaels M, Reyes J, Tzakis A, Gartner JC, et al. Parvovirus B19 infection in pediatric transplant patients. Transplantation 1993;56:835–838.
|
|
14. |
Gallinella G, Manaresi E, Venturoli S, Grazi GL, Musiani M, Zerbini M. Occurrence and clinical role of active parvovirus B19 infection in transplant recipients. Eur J Clin Microbiol Infect Dis 1999;18:811–813.
|
|
15. |
Ndimbie OK, Frezza E, Jordan JA, Koch W, van Thiel DH. Parvovirus B19 in anemic liver transplant recipients. Clin Diagn Lab Immunol 1996;3:756–760.
|
|
16. |
Florea AV, Ionescu DN, Melhem MF. Parvovirus B19 infection in the immunocompromised host. Arch Pathol Lab Med 2007;131:799–804.
|
|
17. |
Wong TY, Chan PK, Leung CB, Szeto CC, Tam JS, Li PK. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus. Am J Kidney Dis 1999;34:1132–1136.
|
|
18. |
Geetha D, Zachary JB, Baldado HM, Kronz JD, Kraus ES. Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature. Clin Transplant 2000;14:586–591.
|
|